Safety
G’zOne Type-V
101
G’zOne Type-V
102
may occur, but such findings have not been confirmed by additional
research. In some cases, other researchers have had difficulty in
reproducing those studies, or in determining the reasons for
inconsistent results.
What is FDA’s role concerning the safety of wireless
phones?
Under the law, FDA does not review the safety of radiation-emitting
consumer products such as wireless phones before they can be sold,
as it does with new drugs or medical devices. However, the agency
has authority to take action if wireless phones are shown to emit
radiofrequency energy (RF) at a level that is hazardous to the user. In
such a case, FDA could require the manufacturers of wireless phones
to notify users of the health hazard and to repair, replace or recall the
phones so that the hazard no longer exists.
Although the existing scientific data do not justify FDA regulatory
actions, FDA has urged the wireless phone industry to take a number
of steps, including the following:
• Support needed research into possible biological effects of RF of the
type emitted by wireless phones;
• Design wireless phones in a way that minimizes any RF exposure to
the user that is not necessary for device function; and
• Cooperate in providing users of wireless phones with the best
possible information on possible effects of wireless phone use on
human health
FDA belongs to an interagency working group of the federal agencies
that have responsibility for different aspects of RF safety to ensure
coordinated efforts at the federal level. The following agencies belong
to this working group:
• National Institute for Occupational Safety and Health
• Environmental Protection Agency
• Federal Communications Commission
• Occupational Safety and Health Administration
• National Telecommunications and Information Administration
The National Institutes of Health participates in some interagency
working group activities, as well.
FDA shares regulatory responsibilities for wireless phones with the
Federal Communications Commission (FCC). All phones that are sold
in the United States must comply with FCC safety guidelines that limit
RF exposure. FCC relies on FDA and other health agencies for safety
questions about wireless phones.
FCC also regulates the base stations that the wireless phone networks
rely upon. While these base stations operate at higher power than do
the wireless phones themselves, the RF exposures that people get
from these base stations are typically thousands of times lower than
those they can get from wireless phones. Base stations are thus not
the primary subject of the safety questions discussed in this
document.
What are the results of the research done already?
The research done thus far has produced conflicting results, and
many studies have suffered from flaws in their research methods.
Animal experiments investigating the effects of radiofrequency energy
(RF) exposures characteristic of wireless phones have yielded
conflicting results that often cannot be repeated in other laboratories.
A few animal studies, however, have suggested that low levels of RF
could accelerate the development of cancer in laboratory animals.
However, many of the studies that showed increased tumor
development used animals that had been genetically engineered or
treated with cancer-causing chemicals so as to be pre-disposed to
develop cancer in the absence of RF exposure. Other studies exposed
